HFS
UTMD icon

Hughes Financial Services’s Utah Medical Products UTMD Stock Holding History

Hughes Financial Services’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$621 Hold
9
– – ﹤0.01% 1035
2026
Q1 		$558 Hold
9
– – ﹤0.01% 913
2025
Q4 		$504 Sell
9
-10
-53% -$580 ﹤0.01% 930
2025
Q3 		$1.09K Hold
19
– – ﹤0.01% 700
2025
Q2 		$1.07K Buy
+19
New +$1.03K ﹤0.01% 692

Other funds holding UTMD

VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hughes Financial Services's UTMD Position: Q2 2026 in Review

Hughes Financial Services held its Utah Medical Products (UTMD) position steady in Q2 2026 at 9 shares worth $621. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

Hughes Financial Services first reported a position in UTMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.09K in Q3 2025. 9 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Hughes Financial Services held 9 shares of Utah Medical Products worth $621 as of Q2 2026.
  • Hughes Financial Services left its Utah Medical Products share count unchanged in Q2 2026.
  • Utah Medical Products made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1035 holding.
  • Hughes Financial Services first reported a position in Utah Medical Products in Q2 2025 and has held it in 5 quarters since.
  • Hughes Financial Services's Utah Medical Products position peaked at $1.09K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.